Crosstalk between cancer cells and bone microenvironment in bone metastasis

Biochemical and Biophysical Research Communications

Volumn 328, Issue 3, 2005, Pages 679-687

  Yoneda, Toshiyuki ^a   Hiraga, Toru ^a  

^a NONE

Author keywords

Bone metastasis; Bone stored growth factors; Breast cancer; Osteoclasts; PTH rP

Indexed keywords

CADHERIN; CALCIUM; CELL ADHESION MOLECULE; CHEMOKINE; COLLAGEN TYPE 4; INTEGRIN; LAMININ; MATRIX METALLOPROTEINASE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; PARATHYROID HORMONE; PHOSPHATE; PLATELET DERIVED GROWTH FACTOR BB; SIALOPROTEIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

BIOLOGY; BONE; BONE DESTRUCTION; BONE LEVEL; BONE MARROW CELL; BONE METASTASIS; BRAIN; BREAST CANCER; CALCIFICATION; CALCIUM BONE LEVEL; CANCER CELL; CANCER LOCALIZATION; CANCER PATIENT; CANCER RELAPSE; CELL CLONE; CELL INTERACTION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CIRCULATION; CYTOLOGY; DISEASE COURSE; HORMONE SYNTHESIS; HUMAN; LIVER METASTASIS; LUNG CANCER; LUNG METASTASIS; MICROENVIRONMENT; MOLECULAR MECHANICS; NONHUMAN; OSTEOBLAST; OSTEOSCLEROSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; STORAGE; STROMA CELL;

EID: 13444306377     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.11.070     Document Type: Review

References (70)

1. D. Rusciano, and M.M. Burger Why do cancer cells metastasize into particular organs? Bio. Essays 14 1992 185 193
2. E. Ruoslahti How cancer spreads Sci. Am. 1996 72 77
3. R.E. Coleman Skeletal complications of malignancy Cancer 80 1997 1588 1594
4. R.E. Coleman, and R.D. Rubens The clinical course of bone metastases from breast cancer Br. J. Cancer 55 1987 61 66
5. S. Paget The distribution of secondary growths in cancer of the breast Lancet 1 1889 571 573
6. L.A. Liotta, and E.C. Kohn The microenvironment of the tumour-host interface Nature 411 2001 375 379
7. I.J. Fidler Critical determinants of metastasis Semin. Cancer Biol. 12 2002 89 96
8. J. Sela Bone remodeling in pathological conditions Calcif. Tissue Res. 23 1977 229 234
9. A. Boyde, E. Maconnachie, S.A. Reid, G. Delling, and G.R. Mundy Scanning electron microscopy in bone pathology Review of methods. Potential and applications Scanning Electron Microsc. 4 1986 1537 1554
10. T. Hiraga, P.J. Williams, G.R. Mundy, and T. Yoneda The bisphosphonate ibandronate promotes apoptosis in MDA-231 human breast cancer cells in bone metastases Cancer Res. 61 2001 4418 4424
11. P.V. Hauschka, A.E. Mavrakos, M.D. Iafrati, S.E. Doleman, and M. Klagsbrun Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose J. Biol. Chem. 261 1986 12665 12674
12. F.W. Orr, J. Varani, M.D. Gondek, P.A. Ward, and G.R. Mundy Chemotactic response of tumor cells to products of resorbing bone Science 203 1979 176 179
13. M.E. Doerr, and J.I. Jones The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells J. Biol. Chem. 271 1996 2443 2447
14. G.R. Mundy Metastasis to bone causes, consequences and therapeutic opportunities Nat. Rev. Cancer 2 2002 584 593
15. G.D. Roodman Mechanism of bone metastasis N. Engl. J. Med. 350 2004 1655 1664
16. J.J. Yin, K. Selander, J.M. Chirgwin, M. Dallas, B.G. Grubbs, R. Wieser, J. Massague, G.R. Mundy, and T.A. Guise TGFβ signaling blockade inhibits PTH-rP secretion by breast cancer cells and bone metastases development J. Clin. Invest. 103 1999 197 206
17. T. Hiraga, and T. Yoneda Stimulation of cyclooxygenase-2 expression by TGF-beta enhances bone metastases in breast cancer J. Bone Miner. Res. 19 Suppl. 1 2004 S129 (Abstract)
18. J.L. Sanders, N. Chattopadhyay, O. Kifor, T. Yamaguchi, R.R. Butters, and E.M. Brown Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines Endocrinology 141 2000 4357 4364
19. H.M. Kronenberg NPT2a-The key to phosphate homeostasis N. Engl. J. Med. 347 2002 1022 1024
20. H. Adwan, T.J. Bauerle, and M.R. Berger Downregulation of osteopontin and bone sialoprotein II is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cells Cancer Gene Ther. 11 2004 109 120
21. S. Harada, and G.A. Rodan Control of osteoblast function and regulation of bone mass Nature 423 2003 349 355
22. H.S. Oh, A. Moharita, J.G. Potian, I.P. Whitehead, J.C. Livingston, T.A. Castro, P.S. Patel, and P. Rameshwar Bone marrow stroma influences transforming growth factor-beta production in breast cancer cells to regulate c-myc activation of the preprotachykinin-I gene in breast cancer cells Cancer Res. 64 2004 6327 6336
23. R. Nyambo, N. Cross, J. Lippitt, I. Holen, G. Bryden, F.C. Hamdy, and C.L. Eaton Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis J. Bone Miner. Res. 19 2004 1712 1721
24. T. Michigami, N. Shimizu, P.J. Williams, M. Niewolna, S.L. Dallas, G.R. Mundy, and T. Yoneda Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and α4β1 integrin enhances production of osteoclast-stimulating activity Blood 96 2000 1953 1960
25. Y. Mori, N. Shimizu, M. Dallas, M. Niewolna, B. Story, P.J. Williams, G.R. Mundy, and T. Yoneda Anti-4 integrin antibody suppresses the development of multiple myeloma and associated with osteoclastic osteolysis Blood 104 2004 2149 2154
26. M. Okazaki, S. Takeshita, S. Kawai, R. Kikuno, A. Tsujimura, A. Kudo, and E. Amann Molecular cloning and characterization of OB-cadherin, a new member of cadherin family expressed in osteoblasts J. Biol. Chem. 269 1994 12092 12098
27. C.M. Feltes, A. Kudo, O. Blaschuk, and S.W. Byers An alternatively spliced cadherin-11 enhances human breast cancer cell invasion Cancer Res. 20 2002 6688 6697
28. D. Tamura, T. Hiraga, A. Myoui, H. Yoshikawa, and T. Yoneda Cadherin-11-mediated interactions between metastatic breast cancer cells and bone marrow stromal/osteoblastic cells enhance bone metastases J. Bone Miner. Res. 19 Suppl. 1 2004 S65 (Abstract)
29. Y. Nefedova, T.H. Landowski, and W.S. Dalton Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms Leukemia 17 2003 1175 1182
30. R. Korah, M. Boots, and R. Wieder Integrin α 5β1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow Cancer Res. 64 2004 4514 4522
31. T. Suda, N. Takahashi, N. Udagawa, E. Jimi, M.T. Gillespie, and T.J. Martin Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families Endocr. Rev. 20 1999 345 357
32. R.J. Thomas, T.A. Guise, J.J. Yin, J. Elliott, N.J. Horwood, T.J. Martin, and M.T. Gillespie Breast cancer cells interact with osteoblasts to support osteoclast formation Endocrinology 140 1999 4451 4458
33. S. Morony, C. Capparelli, I. Sarosi, D.L. Lacey, C.R. Dunstan, and P.J. Kostenuik Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis Cancer Res. 61 2001 4432 4436
34. R.N. Pearse, E.M. Sordillo, S. Yaccoby, B.R. Wong, D.F. Liau, N. Colman, J. Michaeli, J. Epstein, and Y. Choi Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression Proc. Natl. Acad. Sci. USA 98 2001 11581 11586
35. T. Michigami, M. Ihara-Watanabe, M. Yamazaki, and K. Ozono Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma Cancer Res. 61 2001 1637 1644
36. F. Schajowicz, O. Velan, E. Santini Araujo, L. Plantalech, E. Fongi, E. Ottolenghi, and G.A. Fromm Metastases of carcinoma in the Pagetic bone. A report of two cases Clin. Orthop. Rel. Res. 228 1988 290 296
37. A. Hirshberg, P. Leibovich, I. Horowitz, and A. Buchner Metastatic tumors to postextraction sites J. Oral Maxillofac. Surg. 51 1993 1334 1337
38. S. Ramaswamy, K.N. Ross, E.S. Lander, and T.R. Dolub A molecular signature of metastasis in primary solid tumors Nat. Genet. 33 2003 49 54
39. N.J. Bundred, R.A. Walker, W.A. Ratcliffe, J. Warwick, J.M. Morrison, and J.G. Ratcliffe Parathyroid hormone related protein and skeletal morbidity in breast cancer Eur. J. Cancer 28 1992 690 692
40. G.J. Powell, J. Southby, J.A. Danks, R.G. Stillwell, J.A. Hayman, M.A. Henderson, R.C. Bennett, and T.J. Martin Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites Cancer Res. 51 1991 3059 3061
41. S.J. Vargas, M.T. Gillespie, G.J. Powell, J. Southby, J.A. Danks, J.M. Moseley, and T.J. Martin Localization of parathyroid hormone-related protein mRNA expression in metastatic lesions by in situ hybridization J. Bone Miner. Res. 7 1992 971 980
42. N. Kohno, S. Kitazawa, M. Fukase, Y. Sakoda, Y. Kanbara, Y. Furuya, O. Ohashi, Y. Ishikawa, and Y. Saitoh The expression of parathyroid hormone-related protein in human breast cancer with skeletal metastases Surgery Today 24 1994 215 220
43. A. Hiraki, H. Ueoka, A. Bessho, Y. Segawa, N. Takigawa, K. Kiura, M. Tabata, T. Shibayama, K. Gemba, K. Eguchi, S. Hiraki, T. Yoneda, and M. Harada Parathyroid hormone-related protein measured at first visit is an indicator for bone metastases and survival in lung cancer patients with hypercalcemia Cancer 95 2002 1706 1713
44. T.A. Guise, J.J. Yin, S.D. Taylor, Y. Kumagai, M. Dallas, B.F. Boyce, T. Yoneda, and G.R. Mundy Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis J. Clin. Invest. 98 1996 1544 1549
45. D.W. Burton, J. Geller, M. Yang, P. Jiang, I. Barken, R.H. Hastings, R.M. Hoffman, and L.J. Deftos Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrP Prostate 62 2005 275 281
46. W. Guo, and F.G. Giancotti Integrin signalling during tumour progression Nat. Rev. Mol. Cell. Biol. 5 2004 816 826
47. I. Pecheur, O. Peyruchaud, C.M. Serre, J. Guglielmi, C. Voland, F. Bourre, C. Margue, M. Cohen-Solal, A. Buffet, N. Kieffer, and P. Clezardin Integrin αvβ3 expression confers on tumor cells a greater propensity to metastasize to bone FASEB. J. 16 2002 1266 1268
48. J.F. Harms, D.R. Welch, R.S. Samant, L.A. Shevde, M.E. Miele, G.R. Babu, S.F. Goldberg, V.R. Gilman, D.M. Sosnowski, D.A. Campo, C.V. Gay, L.R. Budgeon, R. Mercer, J. Jewell, A.M. Mastro, H.J. Donahue, N. Erin, M.T. Debies, W.J. Meehan, A.L. Jones, G. Mbalaviele, A. Nickols, N.D. Christensen, R. Melly, L.N. Beck, J. Kent, R.K. Rader, J.J. Kotyk, M.D. Pagel, W.F. Westlin, and D.W. Griggs A small molecule antagonist of the alpha (v) beta3 integrin suppresses MDA-MB-435 skeletal metastasis Clin. Exp. Metastasis 21 2004 119 128
49. P.J. Kowalski, M.A. Rubin, and C.G. Kleer E-cadherin expression in primary carcinomas of the breast and its distant metastases Breast Cancer Res. 5 2003 R217 R222
50. G. Mbalaviele, C.R. Dunstan, A. Sasaki, P.J. Williams, G.R. Mundy, and T. Yoneda E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model Cancer Res. 56 1996 4063 4070
51. R.B. Hazan, G.R. Phillips, R.F. Qiao, L. Norton, and S.A. Aaronson Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis J. Cell Biol. 148 2000 779 790
52. P.S. Rudland, A. Platt-Higgins, M. El-Tanani, S. De Silva Rudland, R. Barraclough, J.H. Winstanley, R. Howitt, and C.R. West Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer Cancer Res. 62 2002 3417 3427
53. J.H. Zhang, J. Wang, J. Tang, B. Barnett, J. Dickson, N. Hahsimoto, P. Williams, W. Ma, W. Zheng, T. Yoneda, S. Pageau, and J. Chen Bone sialoprotein promotes bone metastasis of a non-bone-seeking clone of human breast cancer cells Anticancer Res. 24 2004 1361 1368
54. H. Nemoto, S.R. Rittling, H. Yoshitake, K. Furuya, T. Amagasa, K. Tsuji, A. Nifuji, D.T. Denhardt, and M. Noda Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissues J. Bone Miner. Res. 16 2001 652 659
55. S. Akimoto, Y. Nakanishi, M. Sakamoto, Y. Kanai, and S. Hirohashi Laminin 5 β3 and γ2 chains are frequently coexpressed in cancer cells Pathol. Int. 54 2004 688 692
56. M. Nakai, G.R. Mundy, P.J. Williams, B. Boyce, and T. Yoneda A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice Cancer Res. 52 1992 5395 5399
57. T. Michigami, M. Nomizu, Y. Yamada, C. Dunstan, P.J. Williams, G.R. Mundy, and T. Yoneda Growth and dissemination of a newly-established murine B-cell lymphoma cell line is inhibited by multimeric YIGSR peptide Clin. Exp. Metastasis 16 1998 645 654
58. M.J. Arboleda, J.F. Lyons, F.F. Kabbinavar, M.R. Bray, B.E. Snow, R. Ayala, M. Danino, B.Y. Karlan, and D.J. Slamon Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells Cancer Res. 63 2003 196 206
59. L.M. Coussens, B. Fingleton, and L.M. Matrisian Matrix metalloproteinase inhibitors and cancer-trials and tribulations Science 295 2002 2387 2392
60. T. Yoneda, A. Sasaki, C. Dunstan, P.J. Williams, F. Bauss, Y.A. De Clerck, and G.R. Mundy Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2 J. Clin. Invest. 99 1997 2509 2517
61. A. Karadag, K.U. Ogbureke, N.S. Fedarko, and L.W. Fisher Bone sialoprotein, matrix metalloproteinase 2, and αvβ3 integrin in osteotropic cancer cell invasion J. Natl. Cancer Inst. 96 2004 956 965
62. A. Muller, B. Homey, H. Soto, N. Ge, D. Catron, M.E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S.N. Wagner, J.L. Barrera, A. Mohar, E. Verastegui, and A. Zlotnik Involvement of chemokine receptors in breast cancer metastasis Nature 410 2001 50 56
63. S.J. Choi, Y. Oba, Y. Gazitt, M. Alsina, J. Cruz, J. Anderson, and G.D. Roodman Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease J. Clin. Invest. 108 2001 1833 1841
64. T. Yoneda, P.J. Williams, T. Hiraga, M. Niewolna, and R. Nishimura A bone-seeking subclone exhibits different properties from the parental MDA-MB-231 human breast cancer cells and a brain-seeking subclone in vivo and in vitro J. Bone Miner. Res. 16 2001 1486 1495
65. A. Myoui, R. Nishimura, P.J. Williams, T. Hiraga, D. Tamura, T. Michigami, G.R. Mundy, and T. Yoneda C-Src tyrosine kinase activity Is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis Cancer Res 63 2003 5028 5033
66. Y. Kang, P.M. Siegel, W. Shu, M. Drobnjak, S.M. Kakonen, C. Cordo-Cardo, T.A. Guise, and J. Massague A multigenic program mediating breast cancer metastasis to bone Cancer Cell 3 2003 537 549
67. J. Yang, S.A. Mani, J.L. Donaher, S. Ramaswamy, R.A. Itzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson, and R.A. Weinberg Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis Cell 117 2004 927 939
68. B. Yi, P.J. Williams, M. Niewolna, Y. Wang, and T. Yoneda Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer Cancer Res. 62 2002 917 923
69. J.J. Yin, K.S. Mohammad, S.M. Kakonen, S. Harris, J.R. Wu-Wong, J.L. Wessale, R.J. Padley, I.R. Garrett, J.M. Chirgwin, and T.A. Guise A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases Proc. Natl. Acad. Sci. USA 100 2003 10954 10959
70. G.R. Mundy, and T. Yoneda Bisphosphonates as anticancer drugs N. Engl. J. Med. 339 1998 398 400